Amarin Corp Plc (AMRN)

[Pharmacydude]

Golf stud
“if healthnet continues to sell and infringe aren’t they looking at a huge lawsuit if they keep infringing???? “

Yes they are, which is why they will have to seriously reevaluate their current reimbursement plan.

Insurance companies have long felt they were untouchable because prior rulings have stated that merely offering a drug at a lower price is not enough to be found guilty of inducing infringement. For the first time a judge has now stated that they may be inducing infringement by encouraging generics over brand when they know the intended use is patented.

Insurance companies will either have to stop asking why the Pt needs Vascepa (stop requiring a PA) or they will have to cover Vascepa for Pts they know are being treated for CVD prevention.

Amarin should start adding new insurance companies to the lawsuit to serve notice to the industry they will be going after anyone who openly supports generics for CVD.